Status:
COMPLETED
Half-Dose Depot Triptorelin Versus Reduced-Dose Daily Buserelin
Lead Sponsor:
Tehran University of Medical Sciences
Conditions:
Infertility
Eligibility:
FEMALE
Up to 35 years
Phase:
PHASE4
Brief Summary
The purpose of this study is to determine whether half-dose depot triptorelin are as effective as reduced-dose daily buserelin in the controlled ovarian stimulation for intracytoplasmic sperm injectio...
Detailed Description
Significant doubts remain about which type of GnRH agonists \[GnRHa\] administration to be used in controlled ovarian stimulation \[COS\] cycles. The use of a single-dose depot long-acting GnRHa inste...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Candidate for ICSI/ET
- 35 years old or younger
- Serum FSH less than 10 IU/l on day three of the previous menstrual cycle
- No more than two previous IVF/ICSI attempts
- No planned percutaneous epididymal sperm aspiration \[PESA\]
- No planned testicular sperm extraction \[TESE\]
- No known history or risk of severe hyperstimulation
- No evidence of hydrosalpinx
- No major systemic disease
- No uterine abnormality
- No previous ovarian surgery
Exclusion
Key Trial Info
Start Date :
May 1 2005
Trial Type :
INTERVENTIONAL
End Date :
December 1 2006
Estimated Enrollment :
182 Patients enrolled
Trial Details
Trial ID
NCT00461916
Start Date
May 1 2005
End Date
December 1 2006
Last Update
April 18 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dr. Shariati Hospital
Tehran, Tehran Province, Iran, 14114